Parallel Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.7K | Sell |
997
-552
| -36% | -$15.9K | ﹤0.01% | 2007 |
|
|
2025
Q1 | $52K | Buy |
1,549
+50
| +3% | +$1.68K | ﹤0.01% | 1608 |
|
|
2024
Q4 | $76.6K | Buy |
1,499
+10
| +0.7% | +$511 | ﹤0.01% | 1395 |
|
|
2024
Q3 | $76.1K | Hold |
1,489
| – | – | ﹤0.01% | 1393 |
|
|
2024
Q2 | $66.7K | Sell |
1,489
-63
| -4% | -$2.82K | ﹤0.01% | 1370 |
|
|
2024
Q1 | $72.6K | Buy |
1,552
+1,113
| +254% | +$52.1K | ﹤0.01% | 1317 |
|
|
2023
Q4 | $15.6K | Buy |
+439
| New | +$15.6K | ﹤0.01% | 2089 |
|
|
2022
Q4 | – | Sell |
-6
| Closed | – | – | 3376 |
|
|
2022
Q3 | $0 | Buy |
+6
| New | – | ﹤0.01% | 3172 |
|
|
2021
Q4 | – | Sell |
-6
| Closed | – | – | 3108 |
|
|
2021
Q3 | $0 | Buy |
+6
| New | – | ﹤0.01% | 3071 |
|